Cyclacel Pharmaceuticals Inc
CYCC
|
|
| |
|
| Trading Volume | 200,191 |
|
|
0.75 - 0.24 |
| Market Cap Full | $ 3M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | - | -13.9% | -21.6% |
| Q2 | - | - | 1.6% | -64.6% |
| Q3 | - | - | -40.5% | 35.2% |
| Q4 | - | - | -32.3% | -54.3% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| 37.9 | -8.7 | -31.7 | 6.3 | 4.9 | -8.9 | 14.8 | -40.8 | -12.4 | 58.5 | -45.5 | -20.3 |
| 2022 | |||||||||||
| -16.7 | 0.3 | -6.2 | -38.7 | -35.8 | -10 | 5.6 | 47.4 | -13.1 | -4.8 | -40.3 | -19.6 |
| 2021 | |||||||||||
| -10 | -0.4 | 1.6 | 3.5 | -1.8 | -18.1 | -16.2 | 9.7 | -2.6 | -6.8 | -27.5 | 8.7 |
| 2020 | |||||||||||
| 1.5 | -22.9 | -28.6 | 981.2 | 20.4 | -7.4 | 6.5 | -22.8 | -4.5 | -10.7 | 20.3 | 99.2 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -7.1 | -0.4 | -0.5 | -1.5 |
| Q2 | -6.6 | -0.5 | -0.6 | -0.6 |
| Q3 | -7.2 | -0.4 | -0.5 | -0.5 |
| Q4 | 0 | -9 | -0.5 | -0.9 |
| A | -20.85 | -1.9 | -2.1 | -3.4 |